PortfoliosLab logoPortfoliosLab logo
CURE vs. UDOW
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CURE vs. UDOW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares UltraPro Dow30 (UDOW). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CURE achieves a -7.96% return, which is significantly lower than UDOW's 14.65% return. Over the past 10 years, CURE has underperformed UDOW with an annualized return of 13.49%, while UDOW has yielded a comparatively higher 23.82% annualized return.


CURE

1D
-0.55%
1M
13.53%
YTD
-7.96%
6M
-6.00%
1Y
26.46%
3Y*
3.05%
5Y*
1.51%
10Y*
13.49%

UDOW

1D
2.07%
1M
8.49%
YTD
14.65%
6M
11.42%
1Y
51.98%
3Y*
32.31%
5Y*
13.79%
10Y*
23.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. UDOW - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares
-7.96%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%
UDOW
ProShares UltraPro Dow30
14.65%24.46%28.47%32.72%-32.39%65.67%-17.15%75.24%-23.86%99.07%

Correlation

The correlation between CURE and UDOW is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.51

Correlation (3Y)
Calculated over the trailing 3-year period

0.63

Correlation (5Y)
Calculated over the trailing 5-year period

0.68

Correlation (10Y)
Calculated over the trailing 10-year period

0.69

Correlation (All Time)
Calculated using the full available price history since Jun 15, 2011

0.71

The correlation between CURE and UDOW shifts across timeframes, from 0.51 (1 year) to 0.71 (all time), reflecting how their relationship changes across market environments.

CURE vs. UDOW - Sectors Allocation Comparison


Sectors
CURE
UDOW

Healthcare

100.0%
13.1%

Basic Materials

-

4.0%

Communication Services

-

1.9%

Consumer Cyclical

-

11.6%

Consumer Defensive

-

4.4%

Energy

-

2.4%

Financial Services

-

27.2%

Industrials

-

18.4%

Real Estate

-

-

Technology

-

17.1%

Utilities

-

-

Healthcare

CURE
100.0%
UDOW
13.1%

Basic Materials

CURE

-

UDOW
4.0%

Communication Services

CURE

-

UDOW
1.9%

Consumer Cyclical

CURE

-

UDOW
11.6%

Consumer Defensive

CURE

-

UDOW
4.4%

Energy

CURE

-

UDOW
2.4%

Financial Services

CURE

-

UDOW
27.2%

Industrials

CURE

-

UDOW
18.4%

Real Estate

CURE

-

UDOW

-

Technology

CURE

-

UDOW
17.1%

Utilities

CURE

-

UDOW

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CURE vs. UDOW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE
CURE Risk / Return Rank: 2121
Overall Rank
CURE Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 2424
Sortino Ratio Rank
CURE Omega Ratio Rank: 2222
Omega Ratio Rank
CURE Calmar Ratio Rank: 2222
Calmar Ratio Rank
CURE Martin Ratio Rank: 1919
Martin Ratio Rank

UDOW
UDOW Risk / Return Rank: 4444
Overall Rank
UDOW Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
UDOW Sortino Ratio Rank: 4444
Sortino Ratio Rank
UDOW Omega Ratio Rank: 4141
Omega Ratio Rank
UDOW Calmar Ratio Rank: 4242
Calmar Ratio Rank
UDOW Martin Ratio Rank: 4545
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. UDOW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares UltraPro Dow30 (UDOW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CUREUDOWDifference
Sharpe ratioReturn per unit of total volatility

-0.80

Sortino ratioReturn per unit of downside risk

-0.81

Omega ratioGain probability vs. loss probability

1.13

1.24

-0.11

Calmar ratioReturn relative to maximum drawdown

0.85

1.86

-1.01

Martin ratioReturn relative to average drawdown

1.94

6.59

-4.65

CURE vs. UDOW - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.60, which is lower than the UDOW Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of CURE and UDOW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CURE vs. UDOW - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum UDOW drawdown of -80.29%. Use the drawdown chart below to compare losses from any high point for CURE and UDOW.


Loading charts...

Drawdown Indicators


CUREUDOWDifference

Max Drawdown

Largest peak-to-trough decline

-69.19%

-80.29%

+11.10%

Max Drawdown (1Y)

Largest decline over 1 year

-31.10%

-28.07%

-3.03%

Max Drawdown (3Y)

Largest decline over 3 years

-51.93%

-44.83%

-7.10%

Max Drawdown (5Y)

Largest decline over 5 years

-52.23%

-55.79%

+3.56%

Max Drawdown (10Y)

Largest decline over 10 years

-69.19%

-80.29%

+11.10%

Current Drawdown

Current decline from peak

-26.94%

-2.65%

-24.29%

Average Drawdown

Average peak-to-trough decline

-18.16%

-14.37%

-3.79%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.71%

7.94%

+5.77%

Volatility

CURE vs. UDOW - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 14.30% compared to ProShares UltraPro Dow30 (UDOW) at 12.92%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than UDOW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CUREUDOWDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.30%

12.92%

+1.38%

Volatility (6M)

Calculated over the trailing 6-month period

30.87%

29.12%

+1.75%

Volatility (1Y)

Calculated over the trailing 1-year period

44.32%

37.38%

+6.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.84%

44.39%

-0.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.59%

51.84%

-2.25%

CURE vs. UDOW - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than UDOW's 0.95% expense ratio.


Dividends

CURE vs. UDOW - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.16%, less than UDOW's 1.18% yield.


PositionTTM20252024202320222021202020192018201720162015
CURE
Direxion Daily Healthcare Bull 3x Shares
1.16%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%
UDOW
ProShares UltraPro Dow30
1.18%1.38%0.95%0.95%0.83%0.26%0.19%0.61%0.73%0.13%0.26%0.21%

Frequently Asked Questions


CURE and UDOW have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CURE has higher volatility (14.30%) compared to UDOW (12.92%). In terms of maximum drawdown, CURE dropped -69.19% vs UDOW's -80.29%.

On 10-year performance, UDOW leads with 23.82% vs 13.49% for CURE. On fees, UDOW is cheaper at 0.95% per year. On volatility, UDOW has been the lower-risk option at 12.92%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, UDOW has performed better with a 23.82% return vs 13.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

UDOW is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.

UDOW has the higher dividend yield at 1.18%, compared with 1.16% for CURE.

CURE tracks Health Care Select Sector Index (300%), while UDOW tracks Dow Jones Industrial Average (300%). They also come from different issuers: Direxion and ProShares. Their fees differ too: 1.08% for CURE and 0.95% for UDOW.

UDOW currently has the higher Sharpe Ratio (1.40 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CURE and UDOW

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer